Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Open Label Extension ◽

Re: Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A 1-Year, Open-Label Extension Study

The Journal of Urology ◽

10.1016/j.juro.2011.08.004 ◽

2011 ◽

Vol 186 (5) ◽

pp. 1985-1985

Author(s):

Allen D. Seftel

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Open Label Extension ◽

Faculty Opinions recommendation of Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2111965.1706064 ◽

2010 ◽

Author(s):

Peter Gilling ◽

Liam Wilson

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects

International Neurourology Journal ◽

10.5213/inj.2010.14.1.7 ◽

2010 ◽

Vol 14 (1) ◽

pp. 7 ◽

Cited By ~ 6

Author(s):

Tae-Beom Kim ◽

Khae-Hawn Kim ◽

Sang-Jin Yoon

Keyword(s):

Urinary Tract ◽

Prospective Study ◽

Erectile Function ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Open Label ◽

Urinary Tract Symptoms ◽

A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

Urologia Internationalis ◽

10.1159/000315994 ◽

2010 ◽

Vol 85 (1) ◽

pp. 80-87 ◽

Cited By ~ 8

Author(s):

Shinji Tsuritani ◽

Tetsuo Nozaki ◽

Akiou Okumura ◽

Hitomi Kimura ◽

Taizo Kazama

Keyword(s):

Urinary Tract ◽

Multicenter Study ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Efficacy and Safety of Tamsulosin for Treating Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled, Open-Label Non-Inferiority Study

Korean Journal of Urology ◽

10.4111/kju.2012.53.3.178 ◽

2012 ◽

Vol 53 (3) ◽

pp. 178 ◽

Cited By ~ 7

Author(s):

Hyo Serk Lee ◽

Sae Woong Kim ◽

Seung-June Oh ◽

Myung-Soo Choo ◽

Kyu-Sung Lee

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Open Label ◽

Randomized Controlled ◽

Urinary Tract Symptoms ◽

Safety and efficacy of the combination of once-daily tadalafil and alpha-1 blocker in Japanese men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized, placebo-controlled, cross-over study

International Journal of Urology ◽

10.1111/iju.13357 ◽

2017 ◽

Vol 24 (7) ◽

pp. 539-547 ◽

Cited By ~ 11

Author(s):

Masayuki Takeda ◽

Osamu Yokoyama ◽

Masaki Yoshida ◽

Osamu Nishizawa ◽

Kinya Hirata ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Japanese Men ◽

Once Daily ◽

Safety And Efficacy ◽

Urinary Tract Symptoms ◽

An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

Clinical Interventions in Aging ◽

10.2147/cia.s152701 ◽

2018 ◽

Vol Volume 13 ◽

pp. 235-242 ◽

Cited By ~ 1

Author(s):

Pei-Shan Yang ◽

Chien-Lun Chen ◽

Chen-Pang Hou ◽

Yu-Hsiang Lin ◽

Ke-Hung Tsui

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Absorption System ◽

Interventional Study ◽

Open Label ◽

Urinary Tract Symptoms ◽

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis

The World Journal of Men s Health ◽

10.5534/wjmh.2014.32.1.28 ◽

2014 ◽

Vol 32 (1) ◽

pp. 28 ◽

Cited By ~ 9

Author(s):

Sung Won Lee ◽

Jae Seung Paick ◽

Hyun Jun Park ◽

Ji Eon Won ◽

Yoji Morisaki ◽

...

Keyword(s):

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Integrated Analysis ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Faculty Opinions recommendation of Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969665.793470310 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Clinical Trial ◽

Urinary Tract ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Once Daily ◽

Urinary Tract Symptoms ◽